These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9582928)

  • 1. Thwarting host immune responses in periodontal disease.
    Van Dyke TE
    Trends Microbiol; 1998 Mar; 6(3):88-9. PubMed ID: 9582928
    [No Abstract]   [Full Text] [Related]  

  • 2. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration.
    Madianos PN; Papapanou PN; Sandros J
    Infect Immun; 1997 Oct; 65(10):3983-90. PubMed ID: 9316996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis.
    Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M
    Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice.
    Lei L; Li H; Yan F; Xiao Y
    PLoS One; 2013; 8(8):e71849. PubMed ID: 23977160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
    Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
    Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
    Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
    Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection.
    Mydel P; Takahashi Y; Yumoto H; Sztukowska M; Kubica M; Gibson FC; Kurtz DM; Travis J; Collins LV; Nguyen KA; Genco CA; Potempa J
    PLoS Pathog; 2006 Jul; 2(7):e76. PubMed ID: 16895445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontal innate immune mechanisms relevant to obesity.
    Amar S; Leeman S
    Mol Oral Microbiol; 2013 Oct; 28(5):331-41. PubMed ID: 23911141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: involvement of Porphyromonas gingivalis.
    Belibasakis GN; Guggenheim B; Bostanci N
    Innate Immun; 2013 Feb; 19(1):3-9. PubMed ID: 22522430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes.
    Choi JI; Schifferle RE; Yoshimura F; Kim BW
    Infect Immun; 1998 Jan; 66(1):391-3. PubMed ID: 9423888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 negatively regulates Porphyromonas gingivalis fimbria-stimulated fibronectin expression in human gingival fibroblasts.
    Murakami Y; Shoji M; Hirata A; Tanaka S; Hanazawa S; Fujisawa S
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):205-11. PubMed ID: 15681151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of mice and men: animal models of human periodontal disease.
    Fine DH
    J Clin Periodontol; 2009 Nov; 36(11):913-4. PubMed ID: 19735469
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of stress on the inflammatory response to Porphyromonas gingivalis in a mouse subcutaneous chamber model.
    Shapira L; Houri-Haddad Y; Frolov I; Halabi A; Ben-Nathan D
    J Periodontol; 1999 Mar; 70(3):289-93. PubMed ID: 10225545
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Makkawi H; Hoch S; Burns E; Hosur K; Hajishengallis G; Kirschning CJ; Nussbaum G
    Front Cell Infect Microbiol; 2017; 7():359. PubMed ID: 28848717
    [No Abstract]   [Full Text] [Related]  

  • 15. Resolution of inflammation-unraveling mechanistic links between periodontitis and cardiovascular disease.
    Van Dyke TE
    J Dent; 2009 Aug; 37(8):S582-3. PubMed ID: 19501948
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?
    Hajishengallis G
    Microbes Infect; 2009; 11(6-7):637-45. PubMed ID: 19348960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific associations of serum antibody to Porphyromonas gingivalis and inflammatory markers.
    Furuta M; Shimazaki Y; Tanaka S; Takeuchi K; Shibata Y; Takeshita T; Nishimura F; Yamashita Y
    Biomed Res Int; 2015; 2015():897971. PubMed ID: 25756052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete genome sequence of the bacterium Porphyromonas gingivalis TDC60, which causes periodontal disease.
    Watanabe T; Maruyama F; Nozawa T; Aoki A; Okano S; Shibata Y; Oshima K; Kurokawa K; Hattori M; Nakagawa I; Abiko Y
    J Bacteriol; 2011 Aug; 193(16):4259-60. PubMed ID: 21705612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Researchers: how porphyromonas gingivalis contributes to periodontal disease identified.
    J Am Dent Assoc; 2012 Jan; 143(1):15. PubMed ID: 22303556
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.
    Huang N; Shaik-Dasthagirisaheb YB; LaValley MP; Gibson FC
    Mol Oral Microbiol; 2015 Dec; 30(6):438-50. PubMed ID: 25946408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.